Mr. Schreiber holds a B.Sc. degree in Mechanical Engineering and an MBA degree, both from the Technion – Israel Institute of Technology, Haifa, Israel.
Gary holds a BA (Cum Laude) in International Law and Economics from the Hebrew University of Jerusalem; MA degree in International Law and Economics from University of Notre Dame, South Bend, IN, USA.
These include Nilit Ltd. (a global manufacturer of specialized textile yarns), Sapiens (NASDAQ: SPNS), Varicom communications, Telem Teufa and others. Mr. Shattner was one of the founders of PAnGO (international cellular parking leader). He is also a co-founder of Yoramos Ltd. and currently he serves as a Director of several companies. Mr. Shattner holds a B.Sc. in Industrial Engineering from the Technion and an MBA from Tel-Aviv University.
As HealthWatch’s VP R&D, Dror leads all software and QA aspects of the Company’s products, manages agile development cycles and product tracking, for the purpose of bringing the products to maturity and production stability. Dror also brings the concepts of IoT technologies to the product.
Prior to HealthWatch, Dror held the position of R&D Manager at Amobee, leading their exchange product. Prior to that, Dror held the position of Software Team Leader at LSI Logic.
Mr. Bar-Gil holds a Master degree in System Engineering, and B.Sc. in Computer Engineering, both from the Israel Institute of Technology (Technion), Israel.
These include Nilit (a global manufacturer of specialized textile yarns), Delta-Galil (where he was Vice President of Global Strategic Development), Wellsense, Bagir, and Lodzia. Mr. Shoshani holds a degree in Textile Engineering from Leicester University (UK) and the Shenkar College of Engineering Design & Art (Israel).
Dr. Dagan worked as a biotechnology researcher at Enzysurge as well as NMB Medical. She obtained her doctorate from Tel Aviv University in BioTechnology.
Prof. Hasdai attended medical school at Hadassah Medical School, Hebrew University, Jerusalem, graduating cum laude in 1989. He completed his residency in internal medicine at Beilinson Hospital, earning a Master in Internal Medicine at the School of Continuing Medical Education, Tel Aviv University and Board Certification in Internal Medicine in 1994. He was an Interventional Cardiology Fellow at The Mayo Clinic (Rochester, MN) in the Division of Internal Medicine and Cardiovascular Disease. Prof. Hasdai’s research and clinical interests include acute coronary syndromes, heart failure, and coronary interventions and physiology. He is a member of the Clinical Practice Guidelines Committee of the European Society of Cardiology.